Matthieu Guitton

Title: Matthieu Guitton: Innovator in Tinnitus Treatment

Introduction

Matthieu Guitton is a notable inventor based in Le Houlme, France. He has made significant contributions to the field of audiology, particularly in the treatment of tinnitus. With a total of five patents to his name, Guitton's work focuses on innovative methods for addressing cochlear excitotoxicity.

Latest Patents

Guitton's latest patents include methods for the prevention and treatment of tinnitus induced by cochlear excitotoxicity. These methods involve administering a pharmaceutical composition that contains an NMDA receptor antagonist to individuals in need. The treatment can be delivered through appropriate devices and formulations for local administration to the inner ear. The tinnitus targeted by these methods may arise from various causes, including acoustic trauma, presbycusis, ischemia, anoxia, and the use of ototoxic medications. Additionally, Guitton's invention encompasses a novel screening method for identifying compounds effective in treating and preventing tinnitus, which incorporates an electrophysiological test method.

Career Highlights

Throughout his career, Matthieu Guitton has worked with prominent organizations such as Auris Medical AG and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has contributed to his expertise in developing innovative solutions for auditory disorders.

Collaborations

Guitton has collaborated with esteemed colleagues, including Jean-Luc Puel and Remy Pujol. These partnerships have further enhanced his research and development efforts in the field of tinnitus treatment.

Conclusion

Matthieu Guitton's innovative work in the treatment of tinnitus showcases his dedication to improving auditory health. His patents and collaborations reflect a commitment to advancing medical science and providing effective solutions for individuals suffering from tinnitus.